Find a Trial

Trial Summary


Protocol No.CTO-ALLOVIR-P-105-202
StatusOPEN TO ACCRUAL
Principal InvestigatorAbu Zaid, Mohammad
ScopeNational
PhasePhase II/III
Age GroupAdult
TitlePhase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ALVR105 (Viralym-M) Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV-6, and JCV Infection and/or Disease, in High-Risk Patients After Allogeneic Hematopoietic Cell Transplant
Applicable Disease SitesAny Site
Participating InstitutionsIndiana University (IU)
    Treatment TypePrevention
    ContactPhone: (317) 278-5632
    Email: iutrials@iu.edu